🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are looking for new ways to treat triple-negative breast cancer...
Status
Recruiting
Location
UCLA Hematology/Oncology - Parkside ( Site 0021)
Start Date
2025-03-20
Trial ID
NCT06797635
The purpose of this study is to determine the pathological complete tumor r...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT02694718
Treatments Being Tested
This 2 arm study assessed the efficacy and safety of maintenance treatment ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00623805
Treatments Being Tested
There are limited treatment options available for patients with advanced pa...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2004-05
Trial ID
NCT00585078
Treatments Being Tested
This is a multicenter, open-label, non-comparative, three-arm, phase IIa tr...
Status
Completed
Location
Champalimaud Clinical Centre - Champalimaud Foundation
Start Date
2020-10-08
Trial ID
NCT04464174
Treatments Being Tested
This is an open-label, single-arm, multicenter study of capecitabine and be...
Status
Unknown
Location
Clinical Hospital Split, Center of oncology
Start Date
2010-05
Trial ID
NCT01195298
Treatments Being Tested
This 2-arm study assessed the efficacy and safety of bevacizumab (Avastin) ...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00484939
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of AZD6244 (...
Status
Completed
Location
Research Site
Start Date
2006-08
Trial ID
NCT00372944
Treatments Being Tested
The purpose of this study is to determine if Cediranib when added to chemot...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00399035
Purpose: To demonstrate the bioequivalence between Capecitabine Tablets 500...
Status
Unknown
Location
Multiple Locations
Start Date
2018-05
Trial ID
NCT03435666
Treatments Being Tested